Doctors Generic Drugs Marketing Sales 
The Pharma Data
MARCH 9, 2021
This first-to-market generic version of AZOPT ® (brinzolamide ophthalmic suspension) 1% in the U.S. provides patients with another important treatment option,” said Christine Baeder, SVP, Chief Operating Officer US Generics, Teva USA. Currently, one in ten generic prescriptions dispensed in the U.S.
The Pharma Data
DECEMBER 4, 2021
The launch of our first-to-market authorized generic version of Epiduo® Forte Gel in the U.S. provides patients with another important treatment option,” said Christine Baeder, SVP, Chief Operating Officer US Generics, Teva USA. Currently, 1 in 11 generic prescriptions dispensed in the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Creogenic Pharma
APRIL 15, 2023
The Indian pharmaceutical market reached a value of around $27 billion by the end of 2017 and is predicted to experience a CAGR of over 5% for the next five years, reaching over $60 billion by 2022. India is a major player in the global pharmaceutical industry, accounting for almost 20% of the export volume of generic drugs worldwide.
The Pharma Data
MARCH 7, 2022
“The launch of our first generic version of Revlimid® in the U.S. This product adds to our broad generic portfolio of oncology treatments, which accounts for 73% of the essential medicines in this category, as defined by the World Health Organization.”. Currently, 1 in 12 generic prescriptions dispensed in the U.S. About Teva.
FDA Law Blog
SEPTEMBER 6, 2021
Typically, generic sponsors carve out a patent-protected indication or patient population, but technically, any method of use can be carved out as long as FDA determines that the product can still be used safely and effectively without the patent-protected information. The catch is, as we have learned from the GSK v.
pharmaphorum
AUGUST 20, 2020
Shares in Teva were down sharply this week after the US Department of Justice filed a complaint that the company paid illegal kickbacks to patient groups to boost sales of its multiple sclerosis drug Copaxone (glatiramer). The allegation is that Teva’s subsidiaries Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc.
The Pharma Data
MAY 4, 2021
Following the completion of the spin-off of the Upjohn Business (4) in the fourth quarter of 2020, Pfizer now operates as a focused innovative biopharmaceutical company engaged in the discovery, development, manufacturing, marketing, sales and distribution of biopharmaceutical products worldwide. previously $59.4 previously 32.0%
Expert insights. Personalized for you.
52 
Let's personalize your content